Furthermore, to explore the therapeutic potential of metformin on MLL/AF9 AML ex vivo, c-kit+/GFP+ blast cells from MLL/AF9 AML mice were isolated and treated with metformin. This evidence concerns the gene KIT and acute myeloid leukemia.